SCHEMBL29453798

SCHEMBL29453798

N#CC1(Cc2cccc(C(F)(F)F)c2)CCN(C(=O)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 7/20 0.59
▸ CYP3A4 P08684 4/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP2C8 P10632 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PKLR P30613 1/20 0.43
▸ GAA P10253 1/20 0.40
▸ ABL1 P00519 1/20 0.38
▸ BCR P11274 1/20 0.38
▸ USP2 O75604 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ TACR1 P25103 1/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719439 1.00 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22728323 0.91 CYP46A1 (0.47) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719352 0.91 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL29453788 0.91 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719411 0.89 CYP46A1 (0.57) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL29453812 0.89 CYP46A1 (0.57) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL29453644 0.88 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719329 0.88 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719369 0.88 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL29453776 0.88 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback